# US 2015/0104827 A1 · Scalable fermentation process

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104827 A1
- Document ID: US20150104827A1
- Status: Published application
- Kind: A1
- Application number: 14/247,097
- Filed: 2014-04-07
- Published: 2015-04-16
- Earliest claimed: 2005-05-26
- Assignees: Cytos Biotechnology AG
- Inventors: MARCEL EMMERLING; Frank Hennecke; Holger Pfründer; Martin Rhiel; Philipp Steiner
- Web page: https://patentgrep.com/patent/US20150104827A1

## CPC

- C07K 14/005: from viruses
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- A61K 2039/5256: {expressing foreign proteins}
- A61K 2039/5258: {Virus-like particles}
- C12N 2795/00023: Virus like particles [VLP]
- C12N 2795/00051: Methods of production or purification of viral material
- C12N 2795/10051: Methods of production or purification of viral material
- C12N 2795/10061: Methods of inactivation or attenuation
- C12N 2795/18022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2795/18052: relating to complementing cells and packaging systems for producing virus or viral particles
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

This invention provides a robust fermentation process for the expression of a capsid protein of a bacteriophage which is forming a VLP by self-assembly, wherein the process is scalable to a commercial production scale and wherein the expression rate of the capsid protein is controlled to obtain improved yield of soluble capsid protein. This is achieved by combining the advantages of fed-batch culture and of lactose induced expression systems with specific process parameters providing improved repression of the promoter during the growth phase and high plasmid retention throughout the process.

## Claims

### Claim 1

A process for expression of a recombinant capsid protein of a RNA bacteriophage being capable of forming a VIP by self-assembly, said process comprising the steps of:
a.) introducing an expression plasmid into a bacterial host, wherein said expression plasmid comprises an expression construct, wherein said expression construct comprises (i) a first nucleotide sequence encoding said recombinant capsid protein, or mutant or fragment thereof, and (ii) a promoter being inducible by lactose;
b.) cultivating said bacterial host in a medium comprising a major carbon source; wherein said cultivating is performed in batch culture and under conditions under which said promoter is repressed by lac, wherein said lacI is overexpressed by said bacterial host;
c.) feeding said batch culture with said major carbon source; and
d.) inducing said promoter with an inducer, wherein said feeding of said batch culture with said major carbon source is continued.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The process of claim 1, wherein said bacteriophage is selected from the group consisting of:
a.) bacteriophage Qβ;
b.) bacteriophage AP205;
c.) bacteriophage fr;
d.) bacteriophage GA;
e.) bacteriophage SP;
f.) bacteriophage MS2;
g.) bacteriophage M11;
h.) bacteriophage MX1;
i.) bacteriophage NL95;
j.) bacteriophage f2;
k.) bacteriophage PP7 and
l.) bacteriophage R17.

### Claim 4 (depends on 1)

The process of claim 1, wherein said RNA bacteriophage is Qβ.

### Claim 5 (depends on 1)

The process of claim 1, wherein said recombinant capsid protein has the amino acid sequence of SEQ ID NO:5.

### Claim 6 (depends on 1)

The process of claim 1, wherein said expression construct comprises a first stop codon and a second stop codon, wherein said first stop codon is located directly 3′ of said first nucleotide sequence and wherein said second stop codon is located directly 3′ of said first stop codon, and wherein at least one of said first or second stop codon is TAA.

### Claim 7 (depends on 1)

The process of claim 1, wherein said expression construct comprises a first nucleotide sequence and a second nucleotide sequence, wherein said first nucleotide sequence is encoding Qβ CP, or a mutant or fragment thereof, and wherein said second nucleotide sequence is encoding the Qβ A1 protein or a mutant or fragment thereof, and wherein said first and said second nucleotide sequence are separated by exactly one sequence stretch comprising at least one TAA stop codon.

### Claim 8 (depends on 1)

The process of claim 1, wherein said expression construct comprises or alternatively consists of the nucleotide sequence of SEQ H) NO:6.

### Claim 9 (depends on 1)

The process of claim 1, wherein said expression plasmid comprises or preferably consists of the nucleotide sequence of SEQ ID NO:1.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The process of claim 1, wherein said promoter is selected from the group consisting of the
a.) tac promoter;
b.) trc promoter;
c.) tic promoter;
d.) lac promoter;
e.) lacUV5 promoter;
f.) Psyn promoter;
g.) lppa promoter;
h.) lpp-lac promoter;
i.) T7-lac promoter;
j.) T3-lac promoter;
k.) T5-lac promoter; and
l.) a promoter having at least 50% sequence homology to SEQ ID NO:2.

### Claim 12 (depends on 1)

The process of claim 1, wherein said promoter comprises the nucleotide sequence of SEQ ID NO:2.

### Claim 13 (depends on 1)

The process of claim 1, wherein said major carbon source is glycerol.

### Claim 14 (depends on 1)

The process of claim 1, wherein said feeding of said batch culture is performed with a flow rate, wherein said flow rate increases with an exponential coefficient μ, and wherein preferably said exponential coefficient μ is below μmax.

### Claim 15 (depends on 1)

The process of claim 1, wherein said inducing of said promoter is performed by co-feeding said batch culture with said inducer and said major carbon source at a constant flow rate.

### Claim 16 (depends on 1)

The process of claim 1, wherein said inducing of said promoter is performed by co-feeding said batch culture with said inducer and said major carbon source at an increasing flow rate.

### Claim 17 (depends on 15)

The process of claim 15, wherein said inducer is lactose and wherein preferably said lactose and said major carbon source are co-fed to said batch culture in a ratio of about 2:1 to 1:4 (w/w).

### Claim 18 (depends on 1)

The process of claim 1, wherein said inducer is IPTG and wherein preferably the concentration of said IPTG in said medium is 0.001 to 5 mM.

### Claim 19

(canceled)

### Claim 20 (depends on 1)

The process of claim 1, wherein said lacI is overexpressed by said bacterial host, wherein said overexpression is caused by lacIq or lacQ1, preferably by lacIq.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 1)

The process of claim 1, wherein said inducer is lactose and wherein said bacterial host comprises β-galactosidase activity.

### Claim 24 (depends on 1)

The process of claim 1, wherein said cultivating and said feeding of said batch culture and said inducing of said promoter is performed at a temperature which is below the optimal growth temperature of said bacterial host.

### Claim 25 (depends on 9)

The process of claim 9 wherein:
a.) said major carbon source is glycerol;
b.) said feeding of said batch culture is performed with a flow rate, wherein said flow rate increases with an exponential coefficient μ, and wherein preferably said exponential coefficient μ is below μmax;
c.) said inducer is lactose;
d.) and said lactose and said major carbon source are co-fed to said batch culture in a ratio of 2:1 to 1:4 (w/w), preferably 1:1 to 1:3 (w/w), most preferably 1:3 (w/w);
e.) said bacterial host is E. coli RB791; and
f.) said cultivating and feeding of said batch culture and said inducing of said promoter is performed at a temperature of about 30° C.

### Claim 26 (depends on 1)

The process of claim 1 wherein:
a.) said expression plasmid comprises or preferably consists of the nucleotide sequence of SEQ ID NO:30;
b.) said major carbon source is glycerol;
c.) said feeding of said batch culture is performed with a flow rate, wherein said flow rate increases with an exponential coefficient μ, and wherein preferably said exponential coefficient μ is below μmax;
d.) said inducer is lactose;
e.) said lactose and said major carbon source are co-fed to the batch culture in a ratio of 2:1 to 1:4 (w/w), preferably 1:1 to 1:3 (w/w), most preferably 1:3 (w/w);
f.) said bacterial host is E. coli RB791; and
g.) said cultivating and feeding of said hatch culture and said inducing of said promoter is performed at a temperature of about 30° C.

### Claim 27 (depends on 1)

The process of claim 1, wherein throughout steps b.) to d.) of said process oxygen is supplied to said bacterial host by a pO2 in the medium of at least about 40%.

### Claim 28 (depends on 16)

The process of claim 16, wherein said inducer is lactose and wherein preferably said lactose and said major carbon source are co-fed to said batch culture in a ratio of about 2:1 to 1:4 (w/w).
